Molecular Insight Pharmaceuticals Email Formats
Pharmaceutical Manufacturing • 
Cambridge, Massachusetts, United States • 11-20 Employees
Molecular Insight Pharmaceuticals Email Formats
Molecular Insight Pharmaceuticals uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
Key Contacts at Molecular Insight Pharmaceuticals
Pete Manspeaker
Consulting Senior Director Clinical Research
Diane Dahill
Associate Director Of Pharmacovigilance And Drug Safety
Jo Fladger
Director Clinical Operations
David Russo
Director Of Statistical Programming
Marybeth Mallett
Associate Director Clinical Project Management
Marybeth Mallett
Associate Director Clinical Project Management
Company overview
| Headquarters | 160 2nd St, Cambridge, Massachusetts 02142, US |
| Phone number | +16174925554 |
| Website | |
| NAICS | 3254 |
| Founded | 1997 |
| Employees | 11-20 |
| Socials |
About Molecular Insight Pharmaceuticals
As of January 22, 2013, Molecular Insight Pharmaceuticals has been acquired by Progenics Pharmaceuticals. Molecular Insight Pharmaceuticals, Inc. develops therapeutic radiopharmaceuticals and molecular imaging agents for use in oncology and cardiology. The company targets the development of a small-molecule chemistry platform to improve detection of primary and metastatic prostate cancer and to provide a systemic radiotherapy for relapsed and metastatic prostate cancer. Its products include technetium Tc 99m trofolastat, a clinical-stage molecular imaging agent for patients with metastatic prostate cancer; and 131I-MIP-1095, a prostate cancer therapy for systemic delivery of radiotherapy.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Molecular Insight Pharmaceuticals has 6 employees across 4 departments.
Departments
Number of employees
Funding Data
Molecular Insight Pharmaceuticals has never raised funding before.
Molecular Insight Pharmaceuticals Tech Stack
Discover the technologies and tools that power Molecular Insight Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Reverse proxies
Finland
Italy
Frequently asked questions
4.8
40,000 users
